A director at Chemours Co bought 10,200 shares at 19.262USD and the significance rating of the trade was 75/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...
Moody's Ratings (Moody's) assigned a B1 rating to The Chemours Company's ("Chemours") new senior unsecured notes due 2033. Proceeds from the notes will be used for general corporate purposes including the redemption of €441 million of senior unsecured notes maturing in May 2026. The outlook is stabl...
Moody's Ratings (Moody's) confirmed The Chemours Company's ("Chemours") Ba3 Corporate Family Rating ("CFR"), Ba3-PD Probability of Default Rating ("PDR"), Ba1 rating on its senior secured bank credit facilities, and the B1 rating on its senior unsecured notes. The speculative grade liquidity rating ...
Moody's Investors Service (Moody's) has placed under review for downgrade The Chemours Company's ("Chemours") Ba3 corporate family rating ("CFR"), Ba3-PD probability of default rating ("PDR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Previo...
In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.
Credit markets are grossly overstating CC's credit risk with a YTW of 9.084% relative to an Intrinsic YTW of 6.454%, while CDS markets are materially overstating credit risk with a CDS of 355bps relative to an Intrinsic CDS of 180bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with its speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's...
Credit markets are materially overstating CC's credit risk with a YTW of 7.737% relative to an Intrinsic YTW of 5.716%, while CDS markets are overstating credit risk with a CDS of 255bps relative to an Intrinsic CDS of 157bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentives Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensa...
Moody's Investors Service (Moody's) has assigned a Ba1 rating to The Chemours Company's ("Chemours") upsized and amended and extended $960 million Senior Secured Term Loan B3 due 2028 and €515 million Senior Secured Term Loan B3 due 2028. Proceeds from the issuance will be used to repay Chemours' ex...
Credit markets are grossly overstating CC's credit risk with a YTW of 8.024% relative to an Intrinsic YTW of 5.184%, while CDS markets are materially overstating credit risk with a CDS of 363bps relative to an Intrinsic CDS of 172bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's c...
Credit markets are grossly overstating CC's credit risk with a YTW of 8.420% relative to an Intrinsic YTW of 5.720%, while CDS markets are materially overstating credit risk with a CDS of 389bps relative to an Intrinsic CDS of 156bps. Furthermore, Moody's is overstating the company's fundamental credit risk, with it speculative Ba3 credit rating three notches lower than Valens' XO (Baa3) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's c...
Credit markets are grossly overstating CC's credit risk with a YTW of 7.749% and a CDS of 379bps, relative to an Intrinsic YTW of 4.320% and an Intrinsic CDS of 154bps. Furthermore, Moody's is materially overstating the company's fundamental credit risk, with its speculative Ba3 credit rating five notches lower than Valens' IG4+ (Baa1) credit rating. Incentive Dictate Behavior™ analysis highlights mostly positive signals for creditors. CC's compensation framework incentivizes management to impr...
Moody's Investors Service ("Moody's") affirmed the existing ratings of The Chemours Company ("Chemours"), including its Ba3 corporate family rating ("CFR"), Ba1 rating on its senior secured credit facilities, and the B1 rating on its senior unsecured notes. Moody's also changed Chemours' outlook to ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.